Please assess the completion status of the following clinical trial:

Trial Title: Discussing Stopping Cancer Screening and Prognosis With Older Adults

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* English-speaking~* Aged 76 to 89 years~* Scheduled for a routine visit or physical with their PCP in the next 3-12 weeks~* Patient aged 76-79 must have a least one Charlson Comorbidity~* Patient must have undergone CRC screening within the last 10 years~* Women only: patient must have undergone mammography screening within the last 3 years~Exclusion Criteria:~* older adults with dementia~* older adults with a history of colon cancer~* older adults whose last colonoscopy was read as abnormal~* older women who have a history of breast cancer~* older adults whose PCP has already had 5 patients participate in the study~* older women whose last mammogram was read as abnormal

- Gender: ALL
- Minimum Age: 76 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Prognosis Information and Provider Scripts (Type: EXPERIMENTAL): Investigators will send the PCP via secure email the patient's prognosis calculated by the Lee-Schonberg index three days before the patient visit. Investigators will also send PCPs information on patient life expectancy from Cho et al.'s US life tables and scripts developed to sensitively include information on patient prognosis when recommending patients stop being screened for cancer. After five of their patients have participated or recruitment goals are met, investigators will ask PCPs to complete a 10 minute web-based questionnaire about their experience.

Based on this trial design, predict the completion outcome and termination type (if applicable).